GCC Clinical Reference Laboratory Market Research Report Forecast to 2030
The growth of the Gulf Cooperation Council (GCC) clinical reference laboratory market is attributed to the growing prevalence of chronic disorders, increased burden of target diseases, and increasing outsourcing from hospitals. However, stringent regulatory frameworks and high costs of advanced technologies are anticipated to hamper market growth.
Clinical reference laboratories are used to support, diagnose, analysis patient care as well as used for medical research. Laboratory services are an essential part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. The clinical reference laboratory market growth witnessed a significant rise due to the accelerating demand for clinical trials owing to the growing chronic ailments among the expanding populace. Such laboratories are predicted to acquire prominence in the forecast term due to the reduced hospital budget and declining Medicare reimbursements. In addition, the increasing value-based outsourcing from hospitals is likely to augment the clinical laboratory services market share during the forecast period.
The expected growth in the market can be attributed to the growing prevalence of chronic disorders and the increased burden of target diseases. However, the market is also held back by stringent regulatory frameworks and the high costs of advanced technologies. Nevertheless, it is anticipated that the increasing outsourcing from hospitals will create lucrative opportunities for the players operating in the GCC clinical reference laboratory market.
Market Segmentation Based on service, the Gulf Cooperation Council (GCC) clinical reference laboratory market is segmented into stand alone, hospital based, and clinic based.
Based on application, the Gulf Cooperation Council (GCC) clinical reference laboratory market has been segmented into clinical trials and laboratory medicine.
Regional Analysis Increasing value-based outsourcing from hospitals, application of advanced automation technology in reference laboratories, and cost and time savings for hospitals and clinics due to the increase in outsourcing by independent laboratories are the key driving factors for the Gulf Cooperation Council (GCC) clinical reference laboratory market. Clinical reference laboratories have gained immense importance during the COVID-19 pandemic owing to the increasing demand for testing. Key players are focusing on collaborations for providing new lab testing services. For instance, in March 2022, GC Labs entered into a service agreement with Bio Lab in Bahrain and Biotrust in Cambodia, expanding its presence in Asia & Middle East.
Major Players Quest Diagnostics (US), SRL Diagnostics (India), Unilabs (Switzerland), Pure Lab (UAE), Thumbay Labs (UAE), Medsol Diagnostics (UAE), Neuberg Diagnostics, and Alpha Medical Laboratory.
Companies MentionedQuest Diagnostics (US) SRL Diagnostics (India) Unilabs (Switzerland) Pure Lab (UAE) Thumbay Labs (UAE) Medsol Diagnostics (UAE) Neuberg Diagnostics and Alpha Medical Laboratory
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
1 Executive Summary 10
2 Market Introduction 11
2.1 Definition 11
2.2 Scope Of The Study 11
2.3 Research Objective 11
2.4 Market Structure 11
2.5 Assumptions & Limitations 12
3 Research Methodology 13
3.1 Data Mining 13
3.2 Secondary Research 13
3.3 Primary Research 14
3.4 Breakdown Of Primary Respondents 15
3.5 Forecasting Techniques 16
3.6 Research Methodology For Market Size Estimation 17
3.6.1 Bottom-up Approach 18
3.6.2 Top-down Approach 18
3.7 Data Triangulation 19
3.8 Validation 19
4 Market Dynamics 20
4.1 Overview 20
4.2 Drivers 21
4.2.1 Growing Prevalence Of Chronic Disorders 21
4.2.2 Increased Burden Of Target Diseases 21
4.3 Restraints 22
4.3.1 Stringent Regulatory Framework 22
4.3.2 High Costs Of Advanced Technologies 22
4.4 Opportunities 22
4.4.1 Increasing Outsourcing From Hospitals 22
5 Market Factor Analysis 23
5.1 Value Chain Analysis 23
5.1.1 R&D 24
5.1.2 Post-sales Monitoring 24
5.2 Porter's Five Forces Model 25
5.2.1 Threat Of New Entrants 25
5.2.2 Bargaining Power Of Suppliers 26
5.2.3 Threat Of Substitutes 26
5.2.4 Bargaining Power Of Buyers 26
5.2.5 Intensity Of Rivalry 26
5.3 Impact Of Covid-19 On The Gcc Clinical Reference Laboratories Market 26
5.3.1 Impact On Clinical Trials 26
5.3.2 Impact Of Laboratory Developed Tests (Ldt) To Diagnose Covid-19 27
5.3.3 Impact On Test Volume, Revenue, And Staffing 27
6 Gcc Clinical Reference Laboratory Market, By Service 28
6.1 Overview 28
6.2 Hospitals 29
6.3 Stand Alone 30
6.4 Clinic Based 30
7 Gcc Clinical Reference Laboratory Market, By Application 31
7.1 Overview 31
7.2 Clinical Trials 32
7.3 Laboratory Medicine 33
8 Gcc Clinical Reference Laboratory Market, By Country 34
8.1 Overview 34
8.2 Saudi Arabia 37
8.3 United Arab Emirates 37
8.4 Kuwait 38
8.5 Qatar 39
8.6 Oman 39
8.7 Bahrain 40
8.8 Iraq 40
9 Competitive Landscape 41
9.1 Overview 41
9.2 Competitive Benchmarking 42
9.3 The Leading Player In Terms Of The Number Of Developments In The Gcc Clinical Reference Laboratory Market 43
9.4 Key Developments & Growth Strategies 43
9.4.1 Service Launches/Product Approvals 43
9.4.2 Partnerships & Agreements 43
10 Company Profiles 44
10.1 Unilabs 44
10.1.1 Company Overview 44
10.1.2 Financial Overview 44
10.1.3 Services Offered 44
10.1.4 Key Developments 45
10.1.5 Swot Analysis 45
10.1.6 Key Strategies 45
10.2 Quest Diagnostics Incorporated 46
10.2.1 Company Overview 46
10.2.2 Financial Overview 46
10.2.3 Services Offered 47
10.2.4 Key Developments 47
10.2.5 Swot Analysis 48
10.2.6 Key Strategies 48
10.3 Srl Diagnostics 49
10.3.1 Company Overview 49
10.3.2 Financial Overview 49
10.3.3 Services Offered 50
10.3.4 Key Developments 50
10.3.5 Swot Analysis 51
10.3.6 Key Strategies 51
10.4 Neuberg Diagnostics 52
10.4.1 Company Overview 52
10.4.2 Financial Overview 52
10.4.3 Services Offered 52
10.4.4 Key Developments 52
10.4.5 Swot Analysis 53
10.4.6 Key Strategies 53
10.5 Alpha Medical Laboratory 54
10.5.1 Company Overview 54
10.5.2 Financial Overview 54
10.5.3 Services Offered 54
10.5.4 Key Developments 54
10.5.5 Key Strategies 54
10.6 Menalabs 55
10.6.1 Company Overview 55
10.6.2 Financial Overview 55
10.6.3 Services Offered 55
10.6.4 Key Developments 55
10.6.5 Key Strategies 55
10.7 Freiburg Medical Laboratory Middle East (L.L.C) 56
10.7.1 Company Overview 56
10.7.2 Financial Overview 56
10.7.3 Services Offered 56
10.7.4 Key Developments 56
10.7.5 Key Strategies 57
10.8 Medsol Diagnostics 58
10.8.1 Company Overview 58
10.8.2 Financial Overview 58
10.8.3 Services Offered 58
10.8.4 Key Developments 58
10.8.5 Key Strategies 58
10.9 Thumbay Labs 59
10.9.1 Company Overview 59
10.9.2 Financial Overview 59
10.9.3 Services Offered 59
10.9.4 Key Developments 59
10.9.5 Key Strategies 59
10.10 Pure Lab 60
10.10.1 Company Overview 60
10.10.2 Financial Overview 60
10.10.3 Services Offered 60
10.10.4 Key Developments 60
10.10.5 Swot Analysis 61
10.10.6 Key Strategies 61
11 Appendix 62
11.1 References 62
11.2 Related Reports 62
List Of Tables
Table 1 List Of Assumptions & Limitations 12
Table 2 Primary Interviews And Information Gathering Process 15